Ask A Lawyer

Talk to an Actos Diabetic Drug Lawyer for a free case review.

:
Bladder Cancer
Heart Failure
Hypoglycemia
Vision Changes
Other Injuries

Is Actos Safe to Use?

Bladder Cancer Lawsuit Information

It has been 8 months since the June 2011 FDA warning on Actos and many patients and their loved ones still have questions such as is Actos still on market and is Actos safe to use?

The answer to the first question is yes. As of February 2012, Actos remains on the market in the United States.

The answer to the second question is more complicated. The FDA has warned that there is a possibility that the Actos drug causes bladder cancer. The FDA is most concerned about the potential development of the disease when Actos is used for more than one year and the patient has, or has had, bladder cancer. However, that does not mean that the risk is always confined to people who use Actos long term and have a history of bladder cancer.

Contact Our Bladder Cancer Lawyers Today »

It does mean that you should speak to your doctor about Actos safety and about the options available to treat your Type 2 diabetes.

Home  |  Site Map  |  Privacy  |  Disclaimer  |  Copyright

Pennsylvania Bladder Cancer Lawsuits at Monheit Law

© 2002-2013 All rights reserved. Monheit Law, P.C. - PA Bladder Cancer Lawyers - Philadelphia Actos Diabetic Drug Law Firm.

Address: 1368 Barrowdale Road, Jenkintown, PA 19046.  Phone: 215-840-6573  Email: Michael@Monheit.com

Actos Diabetic Drug Attorney Disclaimer:  This website provides general information on Bladder Cancer Lawsuits, Pennsylvania Actos Diabetic Drug Lawsuits and other legal information. Nothing on this site is intended to be legal advice. The materials on this site may be considered advertising. Nothing on this site constitutes the formation of an attorney client relationship. This website is not intended to solicit clients outside the Commonwealth of Pennsylvania. In order to discuss representation, we must personally speak with you and enter into a signed, written agreement for representation. By utilizing this site, you agree to the foregoing.

Related Topics
New Articles